Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-26

Clinical Trial Update: Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery [NA]

View source ↗

Summary

Clinical trial update about using ranibizumab to prevent failure of Ahmed valve glaucoma surgery; study terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Glaucoma | NA | Status: TERMINATED | Results posted: 2013-07-26